 |
|
| LEGISLATIVE |
|
Language to Limit Physician-Owned
Specialty Hospitals Removed from Farm Bill
ACC Urges Members to Contact Lawmakers
on Research Funding |
| REGULATORY
AND PAYER |
|
CMS Announces Changes to 2008 PQRI
Program
CMS Distributes $50M in Grants to
Improve Primary Care Access
CMS To Host Call on April 30 on 2008
PQRI
FDA News Updates
|
| LEGISLATIVE |
Language
to Limit Physician-Owned Specialty Hospitals Removed from
Farm Bill
Senate Finance Committee Chair Max Baucus (D-Mont.)
last week said that the latest version of the farm bill does
not include an amendment that would limit the existence and
growth of physician-owned specialty hospitals by ending Medicare
reimbursements. The ACC opposed the amendment, which was offered
to offset a portion of the legislation's expenditures. The
ACC supports physician ownership in facilities, equipment
or services that benefit patients through the delivery of
appropriate, high quality, medical care. ACC members, many
of whom contacted their lawmakers to express their opposition
to the amendment, were instrumental to its defeat. In addition,
a coalition of 28 House and Senate Republicans sent a letter
to the key congressional committees opposing the amendment.
Although the amendment was removed from the farm bill, it
could be added to other legislative vehicles in need of an
offset. Efforts to undermine physician-owned hospitals have
been present in other bills, such as the House version of
the mental health parity bill and the Children's Health and
Medicare Protection Act of 2007. The ACC urges members to
call their senators and representatives to urge them to oppose
efforts to ban or limit physician-owned specialty hospitals.
To contact your lawmakers directly, call the ACC toll-free
grassroots hotline at 1-800-210-7193.
|
| |
ACC
Urges Members to Contact Lawmakers on Research Funding
As part of the National Coalition for Heart and Stroke
Research, the ACC encourages members to contact their lawmakers
and ask them to sign on to a letter to increase funding for
National Institutes of Health, Centers for Disease Control
and Prevention, and the Health Resources and Services Administration's
heart disease and stroke research, prevention and treatment
programs. The letter is signed by coalition leadership --
co-chairs Reps. Lois Capps (D-CA) and Charles Pickering (R-MS),
and Sens. Byron Dorgan (D-ND) and Mike Crapo (R-IA) –
and will be sent to leadership in the House and Senate Appropriations
Subcommittees on Labor, Health and Human Services, Education
and Related Agencies. Specifically, the letter will be sent
to House Committee Chair David Obey (D-WI) and ranking member
James Walsh (R-NY), and Senate Committee Chair Tom Harkin
(D-IA) and ranking member Arlen Specter (R-PA). The ACC urges
its members to contact their lawmakers and request that they
sign on to the letter. To contact your lawmakers directly,
call the ACC toll-free grassroots hotline at 1-800-210-7193.
|
| |
| REGULATORY
AND PAYER |
CMS
Announces Changes to 2008 PQRI Program
Also on April 17, CMS announced that it is taking
steps to encourage participation in the 2008 Physician Quality
Reporting Initiative (PQRI) by physicians and other eligible
medical professionals. The steps include several new reporting
options to make it easier for medical professionals to participate
in the program and receive feedback. Under the changes, professionals
will have the ability to submit data on quality measures to
a medical registry, which will then report that data to CMS.
The NCDR® was selected from among over 30 self-nominations
to participate in the pilot program to evaluate the use of
clinical registry data to meet PQRI requirements. Through
the IC3 Program, the NCDR's first office-based registry, aggregated
data reporting will be provided for several PQRI measures
on behalf of physicians and practices that provide necessary
consents.
In addition, CMS has altered the PQRI reporting period to
allow professionals to begin reporting in July 2008 and still
be eligible to qualify for an incentive payment in the 2008
program. For more information about the changes and the PQRI
program, visit the CMS Web site here.
|
| |
CMS
Distributes $50M in Grants to Improve Primary Care Access
The Centers for Medicare and Medicaid Services (CMS)
on April 17 announced that it will distribute $50 million
in grants to 20 states to improve access to primary care in
rural and/or underserved areas. The grant, which was created
by the Deficit Reduction Act of 2005, is intended to reduce
unnecessary visits to emergency departments. The funds will
be used by the grantees to establish new community health
centers while extending the hours of operation at existing
clinics; educating beneficiaries about new services; and facilitating
electronic health information exchange between health centers
to provide more coordinated care. The states received $37.5
million last week and will receive the remaining $12.5 million
in 2009. For additional information about the grant, visit
the CMS Web site here.
|
| |
CMS
To Host Call on 2008 PQRI
CMS' Provider Communications Group will host a conference
call on the 2008 Physician Quality Reporting Initiative (PQRI),
the second in a series of national provider calls, on April
30 from 1:30-3:30, EDT. The call will discuss recent changes
to the program and will feature a question-and-answer session
with CMS subject matter experts. In addition, CMS will offer
continuing education units to eligible professionals who participate
in the call. To register, visit http://www2.eventsvc.com/palmettogba/event/2f7d0cda539b41dfb0fa57ad119b2ba9
by April 29 at 1:30 EDT.
|
| |
FDA
News Updates
The Food and Drug Administration (FDA) on April 15
approved the Talent™ Abdominal Stent Graft System, manufactured
by Medtronic Vascular. The stent is approved to repair aneurysms
of the aorta that occur in the abdomen to prevent further
growth and rupture. The device should not be used in patients
who have conditions that could infect the graft or allergies
to device materials, according to FDA. A summary of the safety
and effectiveness and labeling is available on the FDA's Web
site here.
In addition, the FDA on April 21 approved HeartMate II Left
Ventricular Assist System, manufactured by Thoratec Corporation,
the first compact heart assist device to receive agency approval.
When tested in a clinical trial of 126 patients at 26 transplant
centers, 57 percent of patients who used the device survived
to heart transplant, a comparable survival rate to patients
who are treated with currently approved heart assist devices.
HeartMate II is intended for use in some women and small-sized
men who cannot be treated with currently approved devices
because the devices are too large.
|
| |
|
|